A study for a 33 year old man who takes Hysingla - from FDA reports


Summary

21 males aged 33 (±5) who take the same drug are studied. This is a personalized study for a 33 year old male patient who has Plantar Fasciitis. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Oct, 23, 2017

21 males aged 33 (±5) who take Hysingla are studied.


Number of reports submitted per year:

Hysingla for a 33-year old man.

Information of the patient in this study:

  • Age: 33
  • Gender: male
  • Conditions: Plantar Fasciitis
  • Drugs taken:
    • Hysingla (hydrocodone bitartrate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Foot Pain: 0 (0% of males aged 33 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • drug effect delayed
  • feeling abnormal
  • drug ineffective
  • drowsiness
  • diarrhea
  • breakthrough pain
  • nausea
1 - 6 months:
  • insomnia
  • breakthrough pain
  • appetite - decreased
  • weight decreased
  • application site pruritus
  • drug ineffective
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • nausea
  • drug hypersensitivity
  • logorrhea
  • drug ineffective
  • gait disturbance
  • joint pain
  • memory loss
  • chest pain
  • gastrointestinal disorder
  • stress and anxiety

Top conditions involved for these people *:

  • Pain (10 people, 47.62%)
  • Seizures (1 person, 4.76%)
  • Osteoarthritis (1 person, 4.76%)
  • Osgood-Schlatter Disease (1 person, 4.76%)
  • Asthma (1 person, 4.76%)

Top co-used drugs for these people *:

  • Vyvanse (1 person, 4.76%)
  • Vimpat (1 person, 4.76%)
  • Norvir (1 person, 4.76%)
  • Neurontin (1 person, 4.76%)
  • Butrans (1 person, 4.76%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Hysingla, Foot pain Plantar fasciitis

You may be interested in these posts

More posts for: Hysingla, Foot pain Plantar fasciitis